[go: up one dir, main page]

BR9917000A - Processo para preparar derivados dedesaza-adenosina n6-substituìda - Google Patents

Processo para preparar derivados dedesaza-adenosina n6-substituìda

Info

Publication number
BR9917000A
BR9917000A BR9917000-0A BR9917000A BR9917000A BR 9917000 A BR9917000 A BR 9917000A BR 9917000 A BR9917000 A BR 9917000A BR 9917000 A BR9917000 A BR 9917000A
Authority
BR
Brazil
Prior art keywords
preparing
substituted
deesaza
adenosine derivatives
derivatives
Prior art date
Application number
BR9917000-0A
Other languages
English (en)
Inventor
Adam W Sledeskii
Luc Grondard
Matthew R Powers
Tory H Powner
Michael K O'brien
Ching T Tsuei
Patrick Leon
Gregoryg Kubiak
Laurence Pailleres-Hubert
Benoit Viguier
Original Assignee
Aventis Pharm Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharm Prod Inc filed Critical Aventis Pharm Prod Inc
Publication of BR9917000A publication Critical patent/BR9917000A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Patente de Invenção: "PROCESSO PARA PREPARARDERIVADOS DE DESAZA-ADENOSINA N6-SUBSTITUìDA". Estainvenção refere-se a um processo para preparar derivados deadenosina N6-substituída, a intermediários úteis dos mesmos e amétodos de preparar estes intermediários.
BR9917000-0A 1998-12-31 1999-12-15 Processo para preparar derivados dedesaza-adenosina n6-substituìda BR9917000A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11448698P 1998-12-31 1998-12-31
US11602899P 1999-01-15 1999-01-15
PCT/US1999/029841 WO2000040584A2 (en) 1998-12-31 1999-12-15 Process for preparing n6-substituted deaza-adenosine derivatives

Publications (1)

Publication Number Publication Date
BR9917000A true BR9917000A (pt) 2001-12-11

Family

ID=26812247

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917000-0A BR9917000A (pt) 1998-12-31 1999-12-15 Processo para preparar derivados dedesaza-adenosina n6-substituìda

Country Status (15)

Country Link
US (1) US6429315B1 (pt)
EP (1) EP1140933B1 (pt)
JP (1) JP2002534430A (pt)
KR (1) KR20010089751A (pt)
CN (1) CN1383427A (pt)
AT (1) ATE275565T1 (pt)
AU (1) AU2187100A (pt)
BR (1) BR9917000A (pt)
CA (1) CA2358962A1 (pt)
DE (1) DE69920045T2 (pt)
DK (1) DK1140933T3 (pt)
ES (1) ES2228163T3 (pt)
PT (1) PT1140933E (pt)
SI (1) SI1140933T1 (pt)
WO (1) WO2000040584A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2228163T3 (es) 1998-12-31 2005-04-01 Aventis Pharmaceuticals Inc. Procedimiento para preparar derivados de desaza-adenosina n6-sustituidos.
GT200500281A (es) * 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0500785D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
RU2457209C2 (ru) * 2006-04-21 2012-07-27 Новартис Аг Производные пурина, предназначенные для применения в качестве агонистов аденозинового рецептора а2а
GB0607948D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607944D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607950D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607953D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
EP1889846A1 (en) 2006-07-13 2008-02-20 Novartis AG Purine derivatives as A2a agonists
EP1903044A1 (en) * 2006-09-14 2008-03-26 Novartis AG Adenosine Derivatives as A2A Receptor Agonists
KR20090087054A (ko) * 2006-11-10 2009-08-14 노파르티스 아게 시클로펜텐 디올 모노아세테이트 유도체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652366A (en) 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
DE69123974T2 (de) 1990-09-25 1997-05-07 Rhone-Poulenc Rorer International (Holdings) Inc., Greenville, Del. Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen
US5561134A (en) 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US5545769A (en) 1994-09-29 1996-08-13 E. I. Du Pont De Nemours And Company Process for the manufacture of selected halogenated hydrocarbons containing fluorine and hydrogen and compositions provided therein
FR2734822B1 (fr) 1995-05-30 1997-07-04 Rhone Poulenc Rorer Sa Nouveaux derives du 2-azabicyclo(2.2.1)heptane, leur preparation et leur application
US5684159A (en) 1995-05-30 1997-11-04 Rhone-Poulenc Rorer S.A. L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds
AP772A (en) 1996-01-02 1999-10-15 Aventis Pharma Inc Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine.
UA51716C2 (uk) * 1996-07-08 2002-12-16 Авентіс Фармасьютікалз Продактс Інк. Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування
AU732332B2 (en) 1996-09-12 2001-04-12 Aventis Pharmaceuticals Inc. Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines
AU738581B2 (en) 1996-12-11 2001-09-20 Aventis Pharmaceuticals Inc. Preparation of (1S-(1a,2b,3b,4a(S*)))-4-(7-((1-(3-chloro-2- thienyl) methyl)propyl)amino)-3H-imidazo(4,5-b)pyridin-3-yl )-N-ethyl-2,3-dihydroxycylopentanecarboxamide
ES2228163T3 (es) 1998-12-31 2005-04-01 Aventis Pharmaceuticals Inc. Procedimiento para preparar derivados de desaza-adenosina n6-sustituidos.

Also Published As

Publication number Publication date
DE69920045T2 (de) 2005-09-29
CA2358962A1 (en) 2000-07-13
EP1140933B1 (en) 2004-09-08
PT1140933E (pt) 2004-12-31
AU2187100A (en) 2000-07-24
HK1040239A1 (en) 2002-05-31
ATE275565T1 (de) 2004-09-15
DK1140933T3 (da) 2004-12-20
US6429315B1 (en) 2002-08-06
JP2002534430A (ja) 2002-10-15
WO2000040584A3 (en) 2000-11-02
WO2000040584A2 (en) 2000-07-13
CN1383427A (zh) 2002-12-04
SI1140933T1 (en) 2005-02-28
EP1140933A2 (en) 2001-10-10
KR20010089751A (ko) 2001-10-08
DE69920045D1 (de) 2004-10-14
ES2228163T3 (es) 2005-04-01

Similar Documents

Publication Publication Date Title
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
DK0628044T3 (da) Terapeutiske nucleosider
ATE506372T1 (de) Verfahren zur herstellung von nukleosidderivate
BR9917000A (pt) Processo para preparar derivados dedesaza-adenosina n6-substituìda
TR199701647A3 (tr) Ikame edilmis purin türevleri,bunlarin imalat usulü
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
BR0007643A (pt) Processo para obter ésteres de (nitroximetil) fenila de derivados de aspirina, e, (hidroximetil) feniléter de derivados de aspirina
PT1265888E (pt) Processo para producao de derivados de (s)-nicotina 6-substituida e compost0s intermediarios
PT1102781E (pt) Novos co-factores para metiltransferases
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
AU3420099A (en) Process for the production of purine derivatives and intermediates therefor
EA199900741A1 (ru) Способ получения эпросартана
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
PT1252327E (pt) Processo para a separacao enzimatica de racematos de derivados de aminometilaril-ciclo-hexanol
PT1307436E (pt) Processo para a preparacao de derivados de bacatina iii
EA199900740A1 (ru) Способ получения эпросартана (варианты)
YU51401A (sh) Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima
BR9710386B1 (pt) processo de preparação de um composto e processo de transformação do composto.
PT1358179E (pt) Processo de sintese e intermediarios de piridin-2-il-metilamina
BR9909151A (pt) processos para preparação de intermediários
PT1001929E (pt) Processo para o fabrico de acidos 3-ciano-2,4-di-halogeno-5-fluorobenzoicos
EA199801007A1 (ru) Способ биосинтеза, позволяющий получать кобаламины
BR9607850A (pt) Processo para a preparação de um composto e composto
BR9609062A (pt) Processo para a síntese de benzo-tiofenos [B]

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. E 9A. ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DE RPI 1999 DE 28/04/2009.